Wiesner Juan R
Known title: See RemarksCIK: 0001825855
Associated companies
Transaction History
| AVO | ▼ Sell | Open Market | 75,153 | $758K | 3/20/2025 | View on chart |
| AVO | ▼ Sell | Open Market | 75,153 | $758K | 3/19/2025 | View on chart |
| AVO | ▼ Sell | Open Market | 21,892 | $220K | 3/18/2025 | View on chart |
| AVO | ▼ Sell | Tax Withholding | 2,171 | $29K | 1/6/2025 | View on chart |
| AVO | ▲ Buy | Grant | 7,310 | $0 | 1/6/2025 | View on chart |
| AVO | ▼ Sell | Tax Withholding | 1,030 | $15K | 1/5/2025 | View on chart |
| AVO | ▼ Sell | Tax Withholding | 2,006 | $28K | 1/3/2025 | View on chart |
| AVO | ▼ Sell | Tax Withholding | 2,171 | $22K | 1/6/2024 | View on chart |
| AVO | ▲ Buy | Grant | 10,299 | $0 | 1/5/2024 | View on chart |
| AVO | ▼ Sell | Tax Withholding | 2,006 | $20K | 1/3/2024 | View on chart |
| AVO | ▼ Sell | Open Market | 40,000 | $441K | 4/13/2023 | View on chart |
| AVO | ▼ Sell | Open Market | 4,679 | $51K | 3/21/2023 | View on chart |
| AVO | ▲ Buy | Grant | 21,707 | $0 | 1/6/2023 | View on chart |
| AVO | ▼ Sell | Tax Withholding | 2,006 | $23K | 1/3/2023 | View on chart |
| AVO | ▲ Buy | Grant | 20,057 | $0 | 1/3/2022 | View on chart |
| AVO | ▲ Buy | Option Exercise | 6,929 | $83K | 10/6/2021 | View on chart |
| AVO | ▼ Sell | Open Market | 6,929 | $127K | 10/6/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Mission Produce (AVO) Announces 2035 Sales and EBITDA Targets
Mission Produce disclosed its 2035 strategic plan at an investor day, targeting $4 billion in sales and $450 million in EBITDA. An insider purchase of $594 k in shares was reported, indicating confidence from management. Analysts reiterated an overweight stance with a $15 price target, while some commentary notes the current valuation appears high relative to earnings.
Mission Produce (AVO) Announces 2035 Sales and EBITDA Targets. Mission Produce disclosed its 2035 strategic plan at an investor day, targeting $4 billion in sales and $450 million in EBITDA. An insider purchase of $594 k in shares was reported, indicating confidence from management. Analysts reiterated an overweight stance with a $15 price target, while some commentary notes the current valuation appears high relative to earnings.